Skip to main content
The George Institute for Global Health
  • About us

    About us

    We are on a mission to improve global health. Through rigorous, high-quality research, we’re striving to achieve meaningful and lasting change on a local and global scale. 
    Discover who we are
    • Governance
      • Board of directors
      • Executive leadership team
      • Policies
      • Annual reports and financial statements
    • Our people
      • People at The George Institute
      • Emerging thought leaders
      • Distinguished fellows
    • Affiliates and partners
    • Centre for Research, Evidence and Skills Training
    • Innovation
    • Careers
    Medical research careers
    We are hiring!

    Careers

    At The George Institute, your work will help find solutions to some of the world’s greatest health challenges.  We are not just a workplace - we are a community united by a shared mission.
    Work with us
  • Our research

    Our research

    Our research finds solutions to some of the world’s biggest health challenges in critical areas including women’s health, planetary health, and food policy. Within each program, individual projects target specific challenges, providing local solutions to improve global outcomes.   
    Learn more about our research
    • Areas of our research
    • Our research projects
    • Clinical and community trials

    Our Research Mega Menu Cards Container

  • Our impact

    Our impact

    Our high quality, rigorous research makes a real difference to people's health, particularly those facing the most barriers.
    Find out more about the impact of our work
    • Stories of our impact
    • Policy statements and recommendations
    • Impact Report

    Impact Mega Menu Cards Container

  • News & media

    News and media

    Stay up to date with the latest breakthroughs, stories, and developments in global health research from The George Institute. Access articles, videos, and updates that spotlight our work across the world.
    Explore the latest news and insights
    • News
    • Events
    • Videos
    • Podcasts

    News and Media Mega Menu Cards Container

  • Support us

    Support us

    Help us make a lasting impact. By supporting our independent research, you fuel life-saving innovations that improve health outcomes for millions around the globe.
    See how you can support global health innovation
    • Donate
    • Ways to give
    • Your impact
    • Get involved

    Support us Mega Menu Cards Container

    Face of a woman looking ahead

    Be a part of our mission for healthier and longer lives

    Our research relies on the generous support of people like you. Show your support for breakthrough medical research today.
    Donate now
Donate

Filters

Filter by date

Health Star Rating System - Draft Five Year Review Report

Policy & Practice Report

Policy Symposium on SMART Mental Health Project

Policy & Practice Report

Policy Brief: Delivering healthy lives and well-being for women and girls

Policy & Practice Report

SAPPHIRE study: Strengthening China’s rural public health services for hypertension and diabetes care

Background Over the last few decades, the Chinese primary healthcare systemhas progressively weakened following economic liberalisation, rapid growth and changing consumer expectations. In 2009, the Chinese Government launched reforms to provide an essential public health service package’ for primary care activities, including hypertension and type 2 diabetes. Uptake of services varies and large quality gaps exist. Aims The overall goal of this five-year project is to strengthen primary health care systems to enhance uptake of the government’s essential public health services package for hypertension and type 2 diabetes in three diverse regions in China. Methods The SAPPHIRE study will be conducted in four phases, aligned with the Institute for Healthcare Improvement’s ‘Framework for Going to Full Scale’. Phase I (Understand): Rapid health system assessment to develop region- specific logic models. Phase II (Design): Develop a “change package” comprising of clin

Reducing salt consumption in China

Background Excess salt in the diet is associated with high blood pressure and increased risks of stroke, heart attack and kidney disease. This leads to serious health problems or premature death in hundreds of thousands of people in China every year. The problems with excess salt in take are particularly marked in China because food tends to be very salty. On average, Chinese people eat two and half times more salt each day than is recommended by the World Health Organization (WHO). Reducing salt in take has been clearly proven to lower blood pressure.Salt reduction is a focus for the Resolve To Save Lives (RTSL) initiative, which is commencing its salt reduction work in China.  Aims The overall goal of this five-year project is to support the implementation of the RTSL salt reduction program in China. Our work will help identify what works, what doesn’t and how to maximise impact on health with the resources available. Specifically, we will work with RTSL, the Chinese Center for

High-risk pregnancy and NCDs in India- policy and research recommendations

Policy & Practice Report

Reducing salt to save lives: Advocacy, partnerships and research

For more than a decade, The George Institute has championed global action that has the potential to save many millions of lives and billions of dollars in healthcare costs. Our researchers have generated evidence that shows the health benefits and cost-effectiveness of a range of interventions to reduce the amount of salt people eat, and can guide government, industry and consumer behaviour towards healthier societies.   Leads

this is another page 2

j,mhjkhj hjhjhhjhjhjhjm hjhjm

Child page 1

Child page 1

Child page 2

Child page 2

Clinical and community trials

About this study Intracerebral haemorrhage (ICH), bleeding into the brain, is the most serious and least treatable form of stroke, accounting for at least 10% of the 20 million new strokes that occur in the world each year. Patients fortunate enough to survive an ICH are at very high risk of another ICH as well as heart attacks and other serious heart-related events. Whilst there is strong evidence that these risks can be reduced by good control of blood pressure (BP), many patients do not receive any BP lowering treatment or that this treatment is inadequate. TRIDENT aims to determine the benefits of using three different BP medications (each at half the normal dose) in a single pill on preventing another stroke. This capsule with the three medications, is called the Triple Pill. The study is hoping to enrol and treat 1500 people. Recruitment criteria Inclusion criteria Adults with a history of ICH stroke Average resting BP in the 130-160 mmHg range

Clinical and community trials

About this study People with advanced kidney disease or those receiving dialysis often have other diseases related to the heart, brain and blood vessels, known as vascular disease (for example, heart attack, stroke and poor blood circulation). However, few treatments have been proven to prevent these conditions in people with advanced kidney disease. Blood thinners (medicines that prevent blood clots) are frequently used and proven to help other groups of people who are at high risk of vascular disease. There is little understanding of whether blood thinners provide similar benefits in people with advanced kidney disease. The aim of the TRACK study is to find out whether a low dose of blood thinning medicine can reduce heart and vascular disease better than placebo (a look alike tablet that contains no active medication) in people with advanced kidney disease. Recruitment criteria Inclusion: Age ≥18 years, Advanced kidney disease (kidney failure on dialysis, or

Pagination

  • Previous page
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Next page
globe illustration on desktop globe illustration on mobile
The George Institute for Global Health

    Quick links

    • About us
    • Our research
    • Our impact
    • News & media
    • Contact us

    Acknowledgement of country

    The George Institute acknowledges First Peoples and the Traditional Custodians of the many lands upon which we live and work. We pay our respects to Elders past and present, and thank them for ongoing custodianship of waters, lands and skies.

    Our Partners

    The George Institute for Global Health is proud to work in partnership with UNSW Sydney, Imperial College London and the Manipal Academy of Higher Education, India.

    Registered charity logo
    The George Institute for Global Health is a registered charity. ABN 90 085 953 331

    Stay connected

    Enter your details to subscribe to our newsletter.




    By submitting this form, you are agreeing to our Privacy Policy.


    reCAPTCHA helps prevent automated form spam.
    The submit button will be disabled until you complete the CAPTCHA.


    Disclaimer and policy menu

    • Disclaimer
    • Privacy policy
    • Data sharing policy
    • Whistleblower policy
    • Modern slavery statement
    • Working with children and adolescents' policy
    • Research code of conduct policy
    • PHS awards financial COI policy
    • Sitemap
    Affiliated with UNSW Sydney. In partnership with Imperial College London and Manipal Academy of Higher Education, India.

    Copyright © 2025 The George Institute for Global Health.

    Website by Marameo Design

    Cookie Policy | Privacy Policy